AbbVie posts 2026 shareholder voting results
AbbVie Inc. reported the results of its 2026 Annual Meeting of Stockholders, held on May 8, 2026.
Rhea-AI Filing Summary
AbbVie Inc. reported the results of its 2026 Annual Meeting of Stockholders, held on May 8, 2026. Stockholders voted on the election of directors and several other matters.
Director nominees including Jennifer L. Davis, Melody B. Meyer, Robert A. Michael, and Frederick H. Waddell each received more than 1.21 billion votes in favor, with substantially fewer votes against or abstaining, alongside significant broker non-votes. Additional proposals received vote totals such as 1,522,575,012 for and 23,766,564 against on one item, and other items with for votes ranging from about 515.6 million to over 1.29 billion, all with recorded against, abstain, and broker non-vote counts.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Jennifer L. Davis: 1,216,558,754 votes
Votes for Melody B. Meyer: 1,284,771,578 votes
Votes for Robert A. Michael: 1,221,224,370 votes
+5 more
8 metrics
Votes for Jennifer L. Davis
1,216,558,754 votes
Director election at 2026 Annual Meeting
Votes for Melody B. Meyer
1,284,771,578 votes
Director election at 2026 Annual Meeting
Votes for Robert A. Michael
1,221,224,370 votes
Director election at 2026 Annual Meeting
Votes for Frederick H. Waddell
1,225,237,825 votes
Director election at 2026 Annual Meeting
Large proposal for votes
1,522,575,012 votes
For votes on one meeting proposal
Proposal against votes
23,766,564 votes
Against votes on same proposal with 1.52B for
Proposal with lower for votes
515,626,009 votes
For votes on another meeting item
Broker non-votes (several items)
239,399,581 votes
Broker non-votes reported on multiple proposals
Key Terms
Annual Meeting of Stockholders, Broker Non-Votes, Emerging growth company, Senior Notes, +1 more
5 terms
Annual Meeting of Stockholders financial
"AbbVie held its 2026 Annual Meeting of Stockholders on May 8, 2026."
Broker Non-Votes financial
"2,680,369 | | | 239,399,581 Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Emerging growth company regulatory
"Emerging growth company AbbVie held its 2026 Annual Meeting"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Senior Notes financial
"Texas 0.750% Senior Notes due 2027 | | ABBV27"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
Common Stock, $0.01 Par Value financial
"Common Stock, $0.01 Par Value | | ABBV | | New York Stock Exchange"
FAQ
When was AbbVie (ABBV) 2026 Annual Meeting of Stockholders held?
AbbVie’s 2026 Annual Meeting of Stockholders was held on May 8, 2026. At this meeting, shareholders voted on director elections and several other proposals, with detailed for, against, abstain, and broker non-vote counts recorded for each item.
How many votes did AbbVie (ABBV) director nominee Jennifer L. Davis receive?
Jennifer L. Davis received 1,216,558,754 votes for her election. She had 89,839,329 votes against, 2,680,369 abstentions, and there were 239,399,581 broker non-votes reported in connection with her director election item.
What were the AbbVie (ABBV) vote results for director nominee Melody B. Meyer?
Melody B. Meyer received 1,284,771,578 votes for her election. The tally also shows 22,470,074 votes against, 1,836,800 abstentions, and 239,399,581 broker non-votes associated with this director election proposal at the 2026 annual meeting.
How many votes did AbbVie (ABBV) director nominee Robert A. Michael receive in favor?
Robert A. Michael received 1,221,224,370 votes for his election as director. He had 85,865,852 votes against, 1,988,230 abstentions, and there were 239,399,581 broker non-votes reported on this voting item.
What were the AbbVie (ABBV) vote totals for Frederick H. Waddell’s director election?
Frederick H. Waddell received 1,225,237,825 votes for his election. Shareholders cast 81,747,033 votes against, with 2,093,594 abstentions and 239,399,581 broker non-votes recorded for this director election proposal.
Did any AbbVie (ABBV) proposal receive more than 1.5 billion votes in favor?
Yes. One proposal at AbbVie’s 2026 annual meeting received 1,522,575,012 votes for. The same proposal recorded 23,766,564 votes against and 2,136,457 abstentions, indicating a very large level of shareholder support by vote count.
AI-generated analysis. How Rhea-AI works. Not financial advice.
